APA

Tourneur L., Delluc S., Lévy V., Valensi F., Radford-Weiss I., Legrand O., Vargaftig J., Boix C., Macintyre E. A., Varet B., Chiocchia G. & Buzyn A. (20041130). Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. : Cancer research.

Chicago

Tourneur Léa, Delluc Stéphanie, Lévy Vincent, Valensi Françoise, Radford-Weiss Isabelle, Legrand Ollivier, Vargaftig Jacques, Boix Charlotte, Macintyre Elizabeth A, Varet Bruno, Chiocchia Gilles and Buzyn Agnès. 20041130. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. : Cancer research.

Harvard

Tourneur L., Delluc S., Lévy V., Valensi F., Radford-Weiss I., Legrand O., Vargaftig J., Boix C., Macintyre E. A., Varet B., Chiocchia G. and Buzyn A. (20041130). Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. : Cancer research.

MLA

Tourneur Léa, Delluc Stéphanie, Lévy Vincent, Valensi Françoise, Radford-Weiss Isabelle, Legrand Ollivier, Vargaftig Jacques, Boix Charlotte, Macintyre Elizabeth A, Varet Bruno, Chiocchia Gilles and Buzyn Agnès. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. : Cancer research. 20041130.